Key Points Interested in EcoSynthetix Inc.? Here are five stocks we like better. Q2 results weakened: Sales fell 9% year over year to CAD 4.5 million, while adjusted EBITDA declined to a CAD 150,000 loss from a CAD 240,000 profit, primarily due to lower …
Lantheus Holdings (LNTH) shares recently closed at US$101, showing a strong year-to-date return of 50.14% despite a recent 9% dip. The company is considered 3% undervalued with a fair value of $104 per share, driven by an expanding radiodiagnostic pipeline including multiple new product …
Vanguard Portfolio Management has reported a 5.06% ownership stake in Lantheus Holdings Inc. (LNTH) through a Schedule 13G SEC filing. This filing indicates beneficial ownership of 3,300,293 shares as of June 30, 2026, with Vanguard holding sole voting power over 61,822 shares and sole …
Dianthus Therapeutics (Nasdaq:DNTH) is a clinical-stage biotechnology company developing therapies for severe autoimmune diseases. The company's stock has seen significant growth (399.2% in 1 year) but faces risks including past shareholder dilution and current unprofitability. Recent developments include the initiation of a Phase 3 …
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Lantheus Holdings Inc. The ETFs are sorted by market value and provide details such as issuer, management style, focus, expense ratio, AUM, price, and 3-year total return. This information helps investors identify …
Dianthus Therapeutics' stock has reached a new 52-week high of $108.37, driven by strong performance and investor confidence, with a 1-year change of 419.16%. The company is financially sound with more cash than debt and has initiated a Phase 3 trial for its lead …
Gentherm Inc. (THRM) has filed a notice under Rule 144 to sell up to 4,700 shares of its common stock through Merrill Lynch on NASDAQ, with a noted transaction date of July 29, 2026. The filing also details prior stock plan activities, including share …
Curium Pharma is reportedly in advanced discussions to acquire radiopharmaceutical company Lantheus Holdings for approximately $7 billion, with potential for up to $8 billion through contingent value rights. This acquisition would merge two major nuclear medicine and diagnostic imaging companies, aiming to create a …
Northrop Grumman Corp (NYSE:NOC)'s leadership in military aviation received another boost after the U.S. Navy awarded the company a $1.2 billion contract. The award reinforces the company's growing backlog and highlights why rising global defense spending continues to strengthen its long-term investment case. The …
Mizuho maintained an "Outperform" rating for Lantheus Holdings (LNTH) but lowered its price target from $120 to $115. GuruFocus indicates that LNTH is currently 9.8% overvalued with a GF Value™ of $90.52 and a strong GF Score™ of 79/100, driven by high profitability and …
LightInTheBox Holding Co Ltd (LITB) has a robust financial status with a current financial score of 7.00, ranking 21st in the Textiles & Apparel industry. The company's latest quarterly revenue increased by 10.54% year-over-year to $51.98M, and its net profit surged by 916.67% year-over-year. …
This article provides a technical analysis of LightInTheBox Holding Co Ltd (LITB), detailing its current price momentum, support and resistance levels, and various technical indicators. It outlines signals from indicators like MACD, RSI, and moving averages, suggesting a neutral overall signal despite some buy …
LightInTheBox Holding Co Ltd (LITB) has an institutional shareholding score of 3.00, placing it 29th out of 36 in the Textiles & Apparel industry. The institutional shareholding stands at 5.89%, a 2.15% increase quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.64% of …
This article provides a comprehensive stock analysis of Lantheus Holdings Inc (LNTH) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. Despite recent weak market performance, the company exhibits robust fundamentals and is considered …
Rock Springs Capital Management LP has made a new $2.25 million investment in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) by acquiring 26,757 shares. Despite a positive analyst outlook with a "Moderate Buy" rating and an average price target of $117.82, company insiders have sold approximately $7.99 …
BlackRock, Inc. has filed an Amendment No. 1 to a Schedule 13G, disclosing a beneficial ownership of 6.4% in Dianthus Therapeutics Inc. common stock, amounting to 3,504,166 shares as of June 30, 2026. BlackRock holds sole voting power over 3,433,718 shares and sole dispositive …
Lantheus Holdings, Inc. (LNTH) has seen its average 12-month price target raised to $113.82 by 11 analysts, up from $112.91. This new target suggests a potential 5% upside based on the July 27 closing price. The consensus analyst rating remains a "Buy" across 14 …
Gentherm (NASDAQ: THRM) reported increased product revenues of $416.166 million in Q2 2026, up from $375.090 million a year earlier, with net income rising to $4.420 million. The company is advancing its $1 billion Reverse Morris Trust merger with Modine’s Performance Technologies business, expected …
This article provides a comprehensive overview of LightInTheBox Holding Co Ltd's (LITB) cash flow statements, including operating, investing, and financing activities, across various fiscal quarters. It details key financial metrics such as net income, capital expenditures, and changes in working capital, presenting both quarterly …
This article details the shareholder structure of LightInTheBox Holding Co Ltd (LITB), outlining both major shareholders and institutional holdings. Key individual and corporate investors are identified, along with their respective proportions of ownership. The report also provides a historical overview of institutional shareholding over …
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.